Northeast Financial Consultants Inc Pfizer Inc Transaction History

Northeast Financial Consultants Inc

$2.02 Billion
Q1 2024

A detailed history of Northeast Financial Consultants Inc transactions in Pfizer Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 1,243,159 shares of PFE stock, worth $34.8 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

1,243,159

Previous 2,656,610 53.21%

Holding current value

$34.8 Million

Previous $76.5 Million 54.9%

% of portfolio

1.71%

Previous 4.26%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $36.6 Million - $42 Million	-1,413,451 Reduced 53.21%	1,243,159 $34.5 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $5.39 Million - $7 Million	206,107 Added 8.41%	2,656,610 $76.5 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $6.16 Million - $7.2 Million	-191,848 Reduced 7.26%	2,450,503 $81.3 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $18,565 - $21,480	-514 Reduced 0.02%	2,642,351 $96.9 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $27.4 Million - $35.6 Million	694,566 Added 35.65%	2,642,865 $108 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $1.93 Million - $2.52 Million	46,227 Added 2.43%	1,948,299 $99.9 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $2.47 Million - $3.01 Million	-56,350 Reduced 2.88%	1,902,072 $83.2 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $620,989 - $736,298	-13,346 Reduced 0.68%	1,958,422 $103 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $17.5 Million - $21.7 Million	383,242 Added 24.13%	1,971,768 $102 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $545,176 - $808,132	-13,194 Reduced 0.82%	1,588,526 $93.8 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $264,741 - $340,082	-6,745 Reduced 0.42%	1,601,720 $68.9 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $11.1 Million - $12.5 Million	307,977 Added 23.68%	1,608,465 $63 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $277,598 - $313,075	8,289 Added 0.64%	1,300,488 $47.1 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $51.5 Million - $65.5 Million	-1,539,372 Reduced 54.36%	1,292,199 $47.6 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $2.01 Million - $2.36 Million	63,399 Added 2.29%	2,831,571 $104 Million
Q2 2020 Jul 30, 2020	BUY	$30.12 - $36.54 $565,924 - $686,550	18,789 Added 0.68%	2,768,172 $91.5 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $8.84 Million - $12.6 Million	327,189 Added 13.51%	2,749,383 $89.7 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $26.4 Million - $30 Million	801,923 Added 49.49%	2,422,194 $94.9 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $25.2 Million - $32.7 Million	-775,616 Reduced 32.37%	1,620,271 $58.2 Million
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $78,656 - $88,313	2,127 Added 0.09%	2,395,887 $104 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $847,125 - $930,708	-22,590 Reduced 0.93%	2,393,760 $102 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $78.2 Million - $89.2 Million	2,034,004 Added 531.98%	2,416,350 $105 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $32.5 Million - $39.4 Million	-943,371 Reduced 71.16%	382,346 $16.8 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $29,681 - $31,643	-900 Reduced 0.07%	1,325,717 $48.1 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $140,084 - $162,517	-4,390 Reduced 0.33%	1,326,617 $47.1 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $610,221 - $647,465	18,347 Added 1.4%	1,331,007 $48.2 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $40.7 Million - $44.8 Million	1,312,660	1,312,660 $46.9 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Pfizer Inc Transaction History